nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Nateglinide—type 2 diabetes mellitus	0.365	0.5	CbGbCtD
Foscarnet—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.101	0.138	CbGbCtD
Foscarnet—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0899	0.123	CbGbCtD
Foscarnet—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0764	0.104	CbGbCtD
Foscarnet—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0516	0.0706	CbGbCtD
Foscarnet—SLC22A6—Losartan—type 2 diabetes mellitus	0.0472	0.0645	CbGbCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—GRB14—type 2 diabetes mellitus	0.000852	0.0349	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000723	0.0296	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000569	0.0233	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—MMP1—type 2 diabetes mellitus	0.000559	0.0229	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000548	0.0224	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—ND1—type 2 diabetes mellitus	0.0005	0.0205	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000492	0.0201	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000469	0.0192	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CYTB—type 2 diabetes mellitus	0.000458	0.0187	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—THBD—type 2 diabetes mellitus	0.000416	0.017	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—COX2—type 2 diabetes mellitus	0.000393	0.0161	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—UCP2—type 2 diabetes mellitus	0.000379	0.0155	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—UCP3—type 2 diabetes mellitus	0.000379	0.0155	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000374	0.0153	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000369	0.0151	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000355	0.0145	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000328	0.0134	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000319	0.0131	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000317	0.013	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000278	0.0114	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000258	0.0106	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00025	0.0102	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000249	0.0102	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000243	0.00994	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GRB14—type 2 diabetes mellitus	0.000231	0.00945	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—APOB—type 2 diabetes mellitus	0.000225	0.00919	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000213	0.00872	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000212	0.00866	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000206	0.00842	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000204	0.00836	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—MMP1—type 2 diabetes mellitus	0.000186	0.0076	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.00018	0.00738	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.00017	0.00696	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000168	0.00687	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000167	0.00683	CbGpPWpGaD
Foscarnet—Nervousness—Losartan—type 2 diabetes mellitus	0.000163	0.000666	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000162	0.00664	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000162	0.00664	CbGpPWpGaD
Foscarnet—Back pain—Losartan—type 2 diabetes mellitus	0.000162	0.000663	CcSEcCtD
Foscarnet—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000162	0.000663	CcSEcCtD
Foscarnet—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000162	0.000663	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000162	0.00661	CbGpPWpGaD
Foscarnet—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000161	0.000661	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000161	0.00659	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000161	0.00659	CbGpPWpGaD
Foscarnet—Anorexia—Valsartan—type 2 diabetes mellitus	0.000161	0.00066	CcSEcCtD
Foscarnet—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000161	0.000659	CcSEcCtD
Foscarnet—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000161	0.000658	CcSEcCtD
Foscarnet—Myalgia—Metformin—type 2 diabetes mellitus	0.00016	0.000657	CcSEcCtD
Foscarnet—Chest pain—Metformin—type 2 diabetes mellitus	0.00016	0.000657	CcSEcCtD
Foscarnet—Malaise—Irbesartan—type 2 diabetes mellitus	0.00016	0.000657	CcSEcCtD
Foscarnet—Headache—Pioglitazone—type 2 diabetes mellitus	0.00016	0.000654	CcSEcCtD
Foscarnet—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000159	0.000652	CcSEcCtD
Foscarnet—Discomfort—Metformin—type 2 diabetes mellitus	0.000159	0.000649	CcSEcCtD
Foscarnet—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000158	0.000649	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000158	0.00648	CbGpPWpGaD
Foscarnet—Nausea—Glipizide—type 2 diabetes mellitus	0.000158	0.000647	CcSEcCtD
Foscarnet—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000158	0.000647	CcSEcCtD
Foscarnet—Hypotension—Valsartan—type 2 diabetes mellitus	0.000158	0.000647	CcSEcCtD
Foscarnet—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000157	0.000645	CcSEcCtD
Foscarnet—Constipation—Gliclazide—type 2 diabetes mellitus	0.000157	0.000644	CcSEcCtD
Foscarnet—Pain—Gliclazide—type 2 diabetes mellitus	0.000157	0.000644	CcSEcCtD
Foscarnet—Tremor—Losartan—type 2 diabetes mellitus	0.000157	0.000642	CcSEcCtD
Foscarnet—Rash—Glimepiride—type 2 diabetes mellitus	0.000157	0.000641	CcSEcCtD
Foscarnet—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000156	0.000641	CcSEcCtD
Foscarnet—Rash—Sitagliptin—type 2 diabetes mellitus	0.000156	0.000639	CcSEcCtD
Foscarnet—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000156	0.000639	CcSEcCtD
Foscarnet—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000156	0.000639	CcSEcCtD
Foscarnet—Headache—Glimepiride—type 2 diabetes mellitus	0.000155	0.000637	CcSEcCtD
Foscarnet—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000155	0.000636	CcSEcCtD
Foscarnet—Cough—Irbesartan—type 2 diabetes mellitus	0.000155	0.000636	CcSEcCtD
Foscarnet—Headache—Sitagliptin—type 2 diabetes mellitus	0.000155	0.000635	CcSEcCtD
Foscarnet—Anaemia—Losartan—type 2 diabetes mellitus	0.000155	0.000634	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000154	0.00063	CcSEcCtD
Foscarnet—Agitation—Losartan—type 2 diabetes mellitus	0.000154	0.00063	CcSEcCtD
Foscarnet—Oedema—Metformin—type 2 diabetes mellitus	0.000154	0.00063	CcSEcCtD
Foscarnet—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000154	0.000629	CcSEcCtD
Foscarnet—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000153	0.000628	CcSEcCtD
Foscarnet—Flushing—Ramipril—type 2 diabetes mellitus	0.000153	0.000627	CcSEcCtD
Foscarnet—Infection—Metformin—type 2 diabetes mellitus	0.000153	0.000626	CcSEcCtD
Foscarnet—Insomnia—Valsartan—type 2 diabetes mellitus	0.000153	0.000626	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000152	0.000623	CcSEcCtD
Foscarnet—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000152	0.000621	CcSEcCtD
Foscarnet—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000151	0.000621	CcSEcCtD
Foscarnet—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000151	0.00062	CcSEcCtD
Foscarnet—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000151	0.00062	CcSEcCtD
Foscarnet—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000151	0.00062	CcSEcCtD
Foscarnet—Insomnia—Orlistat—type 2 diabetes mellitus	0.000151	0.000618	CcSEcCtD
Foscarnet—Malaise—Losartan—type 2 diabetes mellitus	0.000151	0.000618	CcSEcCtD
Foscarnet—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000151	0.000618	CcSEcCtD
Foscarnet—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000151	0.000617	CcSEcCtD
Foscarnet—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000151	0.000617	CcSEcCtD
Foscarnet—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00015	0.000616	CcSEcCtD
Foscarnet—Somnolence—Valsartan—type 2 diabetes mellitus	0.00015	0.000615	CcSEcCtD
Foscarnet—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00015	0.000614	CcSEcCtD
Foscarnet—Leukopenia—Losartan—type 2 diabetes mellitus	0.00015	0.000614	CcSEcCtD
Foscarnet—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00015	0.000613	CcSEcCtD
Foscarnet—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000149	0.000609	CcSEcCtD
Foscarnet—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000149	0.000609	CcSEcCtD
Foscarnet—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000148	0.000607	CcSEcCtD
Foscarnet—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000148	0.000607	CcSEcCtD
Foscarnet—Palpitations—Losartan—type 2 diabetes mellitus	0.000148	0.000606	CcSEcCtD
Foscarnet—Nausea—Glimepiride—type 2 diabetes mellitus	0.000147	0.000604	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000147	0.00603	CbGpPWpGaD
Foscarnet—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000147	0.000602	CcSEcCtD
Foscarnet—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000147	0.000602	CcSEcCtD
Foscarnet—Asthenia—Glyburide—type 2 diabetes mellitus	0.000147	0.000602	CcSEcCtD
Foscarnet—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000147	0.000602	CcSEcCtD
Foscarnet—Anorexia—Metformin—type 2 diabetes mellitus	0.000147	0.000601	CcSEcCtD
Foscarnet—Cough—Losartan—type 2 diabetes mellitus	0.000146	0.000598	CcSEcCtD
Foscarnet—Fatigue—Valsartan—type 2 diabetes mellitus	0.000146	0.000597	CcSEcCtD
Foscarnet—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000145	0.000595	CcSEcCtD
Foscarnet—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000145	0.000595	CcSEcCtD
Foscarnet—Oedema—Irbesartan—type 2 diabetes mellitus	0.000145	0.000595	CcSEcCtD
Foscarnet—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000145	0.000594	CcSEcCtD
Foscarnet—Pruritus—Glyburide—type 2 diabetes mellitus	0.000145	0.000593	CcSEcCtD
Foscarnet—Constipation—Valsartan—type 2 diabetes mellitus	0.000144	0.000592	CcSEcCtD
Foscarnet—Infection—Irbesartan—type 2 diabetes mellitus	0.000144	0.000591	CcSEcCtD
Foscarnet—Fatigue—Orlistat—type 2 diabetes mellitus	0.000144	0.00059	CcSEcCtD
Foscarnet—Hypotension—Metformin—type 2 diabetes mellitus	0.000144	0.000589	CcSEcCtD
Foscarnet—Pain—Orlistat—type 2 diabetes mellitus	0.000143	0.000585	CcSEcCtD
Foscarnet—Myalgia—Losartan—type 2 diabetes mellitus	0.000142	0.000584	CcSEcCtD
Foscarnet—Arthralgia—Losartan—type 2 diabetes mellitus	0.000142	0.000584	CcSEcCtD
Foscarnet—Chest pain—Losartan—type 2 diabetes mellitus	0.000142	0.000584	CcSEcCtD
Foscarnet—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000142	0.000583	CcSEcCtD
Foscarnet—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000142	0.000582	CcSEcCtD
Foscarnet—Anxiety—Losartan—type 2 diabetes mellitus	0.000142	0.000582	CcSEcCtD
Foscarnet—Rash—Bromocriptine—type 2 diabetes mellitus	0.000141	0.000579	CcSEcCtD
Foscarnet—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000141	0.000578	CcSEcCtD
Foscarnet—Tension—Ramipril—type 2 diabetes mellitus	0.000141	0.000577	CcSEcCtD
Foscarnet—Discomfort—Losartan—type 2 diabetes mellitus	0.000141	0.000577	CcSEcCtD
Foscarnet—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00014	0.000575	CcSEcCtD
Foscarnet—Headache—Bromocriptine—type 2 diabetes mellitus	0.00014	0.000575	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00014	0.000574	CcSEcCtD
Foscarnet—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00014	0.000574	CcSEcCtD
Foscarnet—Nervousness—Ramipril—type 2 diabetes mellitus	0.000139	0.000571	CcSEcCtD
Foscarnet—Dry mouth—Losartan—type 2 diabetes mellitus	0.000139	0.000571	CcSEcCtD
Foscarnet—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000138	0.000567	CcSEcCtD
Foscarnet—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000138	0.000566	CcSEcCtD
Foscarnet—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000138	0.000566	CcSEcCtD
Foscarnet—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000138	0.000565	CcSEcCtD
Foscarnet—Confusional state—Losartan—type 2 diabetes mellitus	0.000138	0.000564	CcSEcCtD
Foscarnet—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000138	0.000563	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000137	0.00562	CbGpPWpGaD
Foscarnet—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000137	0.000562	CcSEcCtD
Foscarnet—Somnolence—Metformin—type 2 diabetes mellitus	0.000137	0.00056	CcSEcCtD
Foscarnet—Oedema—Losartan—type 2 diabetes mellitus	0.000137	0.00056	CcSEcCtD
Foscarnet—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000136	0.000559	CcSEcCtD
Foscarnet—Infection—Losartan—type 2 diabetes mellitus	0.000136	0.000556	CcSEcCtD
Foscarnet—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000136	0.000556	CcSEcCtD
Foscarnet—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000135	0.000555	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3R1—type 2 diabetes mellitus	0.000135	0.00551	CbGpPWpGaD
Foscarnet—Tremor—Ramipril—type 2 diabetes mellitus	0.000134	0.000551	CcSEcCtD
Foscarnet—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000134	0.000548	CcSEcCtD
Foscarnet—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000134	0.000548	CcSEcCtD
Foscarnet—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000133	0.000547	CcSEcCtD
Foscarnet—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000133	0.000546	CcSEcCtD
Foscarnet—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000133	0.000545	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—ATP2A3—type 2 diabetes mellitus	0.000133	0.00543	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000133	0.00543	CbGpPWpGaD
Foscarnet—Fatigue—Metformin—type 2 diabetes mellitus	0.000133	0.000543	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000132	0.000542	CcSEcCtD
Foscarnet—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000132	0.000541	CcSEcCtD
Foscarnet—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000132	0.000541	CcSEcCtD
Foscarnet—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000132	0.000541	CcSEcCtD
Foscarnet—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000132	0.00054	CcSEcCtD
Foscarnet—Agitation—Ramipril—type 2 diabetes mellitus	0.000132	0.00054	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000132	0.00539	CbGpPWpGaD
Foscarnet—Constipation—Metformin—type 2 diabetes mellitus	0.000132	0.000539	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000131	0.00538	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000131	0.00538	CbGpPWpGaD
Foscarnet—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00013	0.000534	CcSEcCtD
Foscarnet—Anorexia—Losartan—type 2 diabetes mellitus	0.00013	0.000533	CcSEcCtD
Foscarnet—Vomiting—Glyburide—type 2 diabetes mellitus	0.00013	0.000533	CcSEcCtD
Foscarnet—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00013	0.000533	CcSEcCtD
Foscarnet—Malaise—Ramipril—type 2 diabetes mellitus	0.000129	0.00053	CcSEcCtD
Foscarnet—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000129	0.00053	CcSEcCtD
Foscarnet—Rash—Glyburide—type 2 diabetes mellitus	0.000129	0.000529	CcSEcCtD
Foscarnet—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000129	0.000529	CcSEcCtD
Foscarnet—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000129	0.000528	CcSEcCtD
Foscarnet—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000128	0.000526	CcSEcCtD
Foscarnet—Headache—Glyburide—type 2 diabetes mellitus	0.000128	0.000525	CcSEcCtD
Foscarnet—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000128	0.000523	CcSEcCtD
Foscarnet—Hypotension—Losartan—type 2 diabetes mellitus	0.000128	0.000523	CcSEcCtD
Foscarnet—Palpitations—Ramipril—type 2 diabetes mellitus	0.000127	0.00052	CcSEcCtD
Foscarnet—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000127	0.000519	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000126	0.00517	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000126	0.00517	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000126	0.00517	CbGpPWpGaD
Foscarnet—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000126	0.000517	CcSEcCtD
Foscarnet—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000126	0.000515	CcSEcCtD
Foscarnet—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000126	0.000515	CcSEcCtD
Foscarnet—Cough—Ramipril—type 2 diabetes mellitus	0.000125	0.000513	CcSEcCtD
Foscarnet—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000125	0.000513	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000124	0.00051	CcSEcCtD
Foscarnet—Convulsion—Ramipril—type 2 diabetes mellitus	0.000124	0.000509	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000124	0.00508	CbGpPWpGaD
Foscarnet—Constipation—Irbesartan—type 2 diabetes mellitus	0.000124	0.000509	CcSEcCtD
Foscarnet—Pain—Irbesartan—type 2 diabetes mellitus	0.000124	0.000509	CcSEcCtD
Foscarnet—Insomnia—Losartan—type 2 diabetes mellitus	0.000124	0.000506	CcSEcCtD
Foscarnet—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000123	0.000503	CcSEcCtD
Foscarnet—Myalgia—Ramipril—type 2 diabetes mellitus	0.000122	0.000501	CcSEcCtD
Foscarnet—Chest pain—Ramipril—type 2 diabetes mellitus	0.000122	0.000501	CcSEcCtD
Foscarnet—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000122	0.000501	CcSEcCtD
Foscarnet—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000122	0.000499	CcSEcCtD
Foscarnet—Anxiety—Ramipril—type 2 diabetes mellitus	0.000122	0.000499	CcSEcCtD
Foscarnet—Nausea—Glyburide—type 2 diabetes mellitus	0.000122	0.000498	CcSEcCtD
Foscarnet—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000122	0.000498	CcSEcCtD
Foscarnet—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000122	0.000498	CcSEcCtD
Foscarnet—Somnolence—Losartan—type 2 diabetes mellitus	0.000121	0.000498	CcSEcCtD
Foscarnet—Asthenia—Valsartan—type 2 diabetes mellitus	0.000121	0.000497	CcSEcCtD
Foscarnet—Discomfort—Ramipril—type 2 diabetes mellitus	0.000121	0.000495	CcSEcCtD
Foscarnet—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00012	0.000493	CcSEcCtD
Foscarnet—Asthenia—Orlistat—type 2 diabetes mellitus	0.00012	0.000491	CcSEcCtD
Foscarnet—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00012	0.00049	CcSEcCtD
Foscarnet—Pruritus—Valsartan—type 2 diabetes mellitus	0.000119	0.00049	CcSEcCtD
Foscarnet—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000119	0.00049	CcSEcCtD
Foscarnet—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000119	0.000487	CcSEcCtD
Foscarnet—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000119	0.000486	CcSEcCtD
Foscarnet—Confusional state—Ramipril—type 2 diabetes mellitus	0.000118	0.000484	CcSEcCtD
Foscarnet—Pruritus—Orlistat—type 2 diabetes mellitus	0.000118	0.000484	CcSEcCtD
Foscarnet—Fatigue—Losartan—type 2 diabetes mellitus	0.000118	0.000483	CcSEcCtD
Foscarnet—Oedema—Ramipril—type 2 diabetes mellitus	0.000117	0.00048	CcSEcCtD
Foscarnet—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000117	0.000479	CcSEcCtD
Foscarnet—Pain—Losartan—type 2 diabetes mellitus	0.000117	0.000479	CcSEcCtD
Foscarnet—Constipation—Losartan—type 2 diabetes mellitus	0.000117	0.000479	CcSEcCtD
Foscarnet—Rash—Gliclazide—type 2 diabetes mellitus	0.000116	0.000475	CcSEcCtD
Foscarnet—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000116	0.000474	CcSEcCtD
Foscarnet—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000116	0.000473	CcSEcCtD
Foscarnet—Headache—Gliclazide—type 2 diabetes mellitus	0.000115	0.000472	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000115	0.0047	CbGpPWpGaD
Foscarnet—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000115	0.00047	CcSEcCtD
Foscarnet—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000115	0.00047	CcSEcCtD
Foscarnet—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000115	0.00047	CcSEcCtD
Foscarnet—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000114	0.000468	CcSEcCtD
Foscarnet—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000113	0.000464	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—THBD—type 2 diabetes mellitus	0.000113	0.00462	CbGpPWpGaD
Foscarnet—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000113	0.000461	CcSEcCtD
Foscarnet—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000112	0.000458	CcSEcCtD
Foscarnet—Dizziness—Valsartan—type 2 diabetes mellitus	0.000112	0.000458	CcSEcCtD
Foscarnet—Anorexia—Ramipril—type 2 diabetes mellitus	0.000112	0.000457	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.00011	0.00452	CbGpPWpGaD
Foscarnet—Dizziness—Orlistat—type 2 diabetes mellitus	0.00011	0.000452	CcSEcCtD
Foscarnet—Asthenia—Metformin—type 2 diabetes mellitus	0.00011	0.000452	CcSEcCtD
Foscarnet—Hypotension—Ramipril—type 2 diabetes mellitus	0.000109	0.000448	CcSEcCtD
Foscarnet—Nausea—Gliclazide—type 2 diabetes mellitus	0.000109	0.000447	CcSEcCtD
Foscarnet—Pruritus—Metformin—type 2 diabetes mellitus	0.000109	0.000446	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000108	0.00443	CbGpPWpGaD
Foscarnet—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000108	0.000442	CcSEcCtD
Foscarnet—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000108	0.000442	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000108	0.0044	CbGpPWpGaD
Foscarnet—Vomiting—Valsartan—type 2 diabetes mellitus	0.000107	0.00044	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000107	0.00439	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—BHMT—type 2 diabetes mellitus	0.000107	0.00438	CbGpPWpGaD
Foscarnet—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000107	0.000437	CcSEcCtD
Foscarnet—Rash—Valsartan—type 2 diabetes mellitus	0.000106	0.000436	CcSEcCtD
Foscarnet—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000106	0.000436	CcSEcCtD
Foscarnet—Vomiting—Orlistat—type 2 diabetes mellitus	0.000106	0.000435	CcSEcCtD
Foscarnet—Insomnia—Ramipril—type 2 diabetes mellitus	0.000106	0.000434	CcSEcCtD
Foscarnet—Headache—Valsartan—type 2 diabetes mellitus	0.000106	0.000434	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000105	0.00431	CbGpPWpGaD
Foscarnet—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000105	0.000431	CcSEcCtD
Foscarnet—Rash—Orlistat—type 2 diabetes mellitus	0.000105	0.000431	CcSEcCtD
Foscarnet—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000105	0.000431	CcSEcCtD
Foscarnet—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000105	0.000431	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000105	0.00428	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000105	0.00428	CbGpPWpGaD
Foscarnet—Headache—Orlistat—type 2 diabetes mellitus	0.000105	0.000428	CcSEcCtD
Foscarnet—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000104	0.000428	CcSEcCtD
Foscarnet—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000427	CcSEcCtD
Foscarnet—Somnolence—Ramipril—type 2 diabetes mellitus	0.000104	0.000427	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000104	0.00425	CbGpPWpGaD
Foscarnet—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000103	0.000422	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000103	0.00421	CbGpPWpGaD
Foscarnet—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000103	0.000421	CcSEcCtD
Foscarnet—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000102	0.000417	CcSEcCtD
Foscarnet—Dizziness—Metformin—type 2 diabetes mellitus	0.000102	0.000417	CcSEcCtD
Foscarnet—Fatigue—Ramipril—type 2 diabetes mellitus	0.000101	0.000414	CcSEcCtD
Foscarnet—Nausea—Valsartan—type 2 diabetes mellitus	0.0001	0.000411	CcSEcCtD
Foscarnet—Constipation—Ramipril—type 2 diabetes mellitus	0.0001	0.00041	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—SRC—type 2 diabetes mellitus	9.96e-05	0.00408	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	9.96e-05	0.00407	CbGpPWpGaD
Foscarnet—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.93e-05	0.000407	CcSEcCtD
Foscarnet—Nausea—Orlistat—type 2 diabetes mellitus	9.91e-05	0.000406	CcSEcCtD
Foscarnet—Asthenia—Losartan—type 2 diabetes mellitus	9.8e-05	0.000402	CcSEcCtD
Foscarnet—Vomiting—Metformin—type 2 diabetes mellitus	9.78e-05	0.000401	CcSEcCtD
Foscarnet—Rash—Metformin—type 2 diabetes mellitus	9.7e-05	0.000397	CcSEcCtD
Foscarnet—Dermatitis—Metformin—type 2 diabetes mellitus	9.69e-05	0.000397	CcSEcCtD
Foscarnet—Pruritus—Losartan—type 2 diabetes mellitus	9.66e-05	0.000396	CcSEcCtD
Foscarnet—Feeling abnormal—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000395	CcSEcCtD
Foscarnet—Headache—Metformin—type 2 diabetes mellitus	9.63e-05	0.000395	CcSEcCtD
Foscarnet—Dizziness—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000393	CcSEcCtD
Foscarnet—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.58e-05	0.000392	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	9.57e-05	0.00391	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ATP2A2—type 2 diabetes mellitus	9.53e-05	0.0039	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGDS—type 2 diabetes mellitus	9.36e-05	0.00383	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AANAT—type 2 diabetes mellitus	9.36e-05	0.00383	CbGpPWpGaD
Foscarnet—Diarrhoea—Losartan—type 2 diabetes mellitus	9.34e-05	0.000383	CcSEcCtD
Foscarnet—Body temperature increased—Ramipril—type 2 diabetes mellitus	9.26e-05	0.000379	CcSEcCtD
Foscarnet—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.26e-05	0.000379	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—TRPC6—type 2 diabetes mellitus	9.25e-05	0.00378	CbGpPWpGaD
Foscarnet—Vomiting—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.000378	CcSEcCtD
Foscarnet—Rash—Irbesartan—type 2 diabetes mellitus	9.15e-05	0.000375	CcSEcCtD
Foscarnet—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000375	CcSEcCtD
Foscarnet—Nausea—Metformin—type 2 diabetes mellitus	9.13e-05	0.000374	CcSEcCtD
Foscarnet—Headache—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000373	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—F7—type 2 diabetes mellitus	9.09e-05	0.00372	CbGpPWpGaD
Foscarnet—Dizziness—Losartan—type 2 diabetes mellitus	9.03e-05	0.00037	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CDO1—type 2 diabetes mellitus	8.88e-05	0.00363	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GPD2—type 2 diabetes mellitus	8.88e-05	0.00363	CbGpPWpGaD
Foscarnet—Vomiting—Losartan—type 2 diabetes mellitus	8.68e-05	0.000356	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	8.64e-05	0.00354	CbGpPWpGaD
Foscarnet—Nausea—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000353	CcSEcCtD
Foscarnet—Rash—Losartan—type 2 diabetes mellitus	8.61e-05	0.000353	CcSEcCtD
Foscarnet—Dermatitis—Losartan—type 2 diabetes mellitus	8.6e-05	0.000353	CcSEcCtD
Foscarnet—Headache—Losartan—type 2 diabetes mellitus	8.56e-05	0.000351	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	8.55e-05	0.0035	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	8.53e-05	0.00349	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	8.53e-05	0.00349	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AK1—type 2 diabetes mellitus	8.47e-05	0.00347	CbGpPWpGaD
Foscarnet—Asthenia—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000344	CcSEcCtD
Foscarnet—Pruritus—Ramipril—type 2 diabetes mellitus	8.29e-05	0.00034	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	8.25e-05	0.00338	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	8.25e-05	0.00338	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	8.21e-05	0.00336	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	8.21e-05	0.00336	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	8.19e-05	0.00335	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ADRA2A—type 2 diabetes mellitus	8.14e-05	0.00333	CbGpPWpGaD
Foscarnet—Nausea—Losartan—type 2 diabetes mellitus	8.11e-05	0.000332	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—TIMP1—type 2 diabetes mellitus	8.1e-05	0.00332	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PLAT—type 2 diabetes mellitus	8.1e-05	0.00332	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	8.06e-05	0.0033	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	8.05e-05	0.00329	CbGpPWpGaD
Foscarnet—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.01e-05	0.000328	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	8e-05	0.00328	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	7.96e-05	0.00326	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC5A4—type 2 diabetes mellitus	7.81e-05	0.0032	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MAT1A—type 2 diabetes mellitus	7.81e-05	0.0032	CbGpPWpGaD
Foscarnet—Dizziness—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000317	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—NOS1—type 2 diabetes mellitus	7.62e-05	0.00312	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.55e-05	0.00309	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ND1—type 2 diabetes mellitus	7.55e-05	0.00309	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ENPP1—type 2 diabetes mellitus	7.55e-05	0.00309	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—G6PC—type 2 diabetes mellitus	7.55e-05	0.00309	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HBA2—type 2 diabetes mellitus	7.55e-05	0.00309	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	7.45e-05	0.00305	CbGpPWpGaD
Foscarnet—Vomiting—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000305	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PTPN1—type 2 diabetes mellitus	7.41e-05	0.00303	CbGpPWpGaD
Foscarnet—Rash—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000303	CcSEcCtD
Foscarnet—Dermatitis—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000302	CcSEcCtD
Foscarnet—Headache—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000301	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GCGR—type 2 diabetes mellitus	7.31e-05	0.00299	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RASGRP1—type 2 diabetes mellitus	7.29e-05	0.00298	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	7.01e-05	0.00287	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.98e-05	0.00286	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	6.97e-05	0.00285	CbGpPWpGaD
Foscarnet—Nausea—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000285	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYTB—type 2 diabetes mellitus	6.9e-05	0.00282	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—OXCT1—type 2 diabetes mellitus	6.9e-05	0.00282	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.74e-05	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SRD5A1—type 2 diabetes mellitus	6.73e-05	0.00275	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	6.69e-05	0.00274	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SOD1—type 2 diabetes mellitus	6.61e-05	0.0027	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	6.5e-05	0.00266	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	6.46e-05	0.00264	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—STAR—type 2 diabetes mellitus	6.42e-05	0.00263	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ACACA—type 2 diabetes mellitus	6.42e-05	0.00263	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HSD17B3—type 2 diabetes mellitus	6.42e-05	0.00263	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.41e-05	0.00263	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GNB3—type 2 diabetes mellitus	6.39e-05	0.00261	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IGF2—type 2 diabetes mellitus	6.27e-05	0.00257	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCC8—type 2 diabetes mellitus	6.15e-05	0.00252	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CBS—type 2 diabetes mellitus	6.15e-05	0.00252	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—APOB—type 2 diabetes mellitus	6.09e-05	0.00249	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—COX2—type 2 diabetes mellitus	5.92e-05	0.00242	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC5A2—type 2 diabetes mellitus	5.92e-05	0.00242	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NCOA6—type 2 diabetes mellitus	5.82e-05	0.00238	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HSD11B1—type 2 diabetes mellitus	5.72e-05	0.00234	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—UCP2—type 2 diabetes mellitus	5.72e-05	0.00234	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—UCP3—type 2 diabetes mellitus	5.72e-05	0.00234	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.61e-05	0.00229	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.53e-05	0.00226	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CD36—type 2 diabetes mellitus	5.53e-05	0.00226	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.5e-05	0.00225	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PPP2CA—type 2 diabetes mellitus	5.46e-05	0.00223	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.45e-05	0.00223	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PCK1—type 2 diabetes mellitus	5.38e-05	0.0022	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	5.35e-05	0.00219	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	5.35e-05	0.00219	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.27e-05	0.00216	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.23e-05	0.00214	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.2e-05	0.00213	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.17e-05	0.00211	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MMP1—type 2 diabetes mellitus	5.04e-05	0.00206	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HK1—type 2 diabetes mellitus	5.04e-05	0.00206	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.93e-05	0.00202	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CALM1—type 2 diabetes mellitus	4.89e-05	0.002	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GCKR—type 2 diabetes mellitus	4.86e-05	0.00199	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—KCNJ11—type 2 diabetes mellitus	4.86e-05	0.00199	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HSD3B2—type 2 diabetes mellitus	4.86e-05	0.00199	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—LPA—type 2 diabetes mellitus	4.86e-05	0.00199	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—APOA1—type 2 diabetes mellitus	4.82e-05	0.00197	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALDOB—type 2 diabetes mellitus	4.66e-05	0.00191	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PRKCB—type 2 diabetes mellitus	4.6e-05	0.00188	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.55e-05	0.00186	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—NOS2—type 2 diabetes mellitus	4.54e-05	0.00186	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.45e-05	0.00182	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.34e-05	0.00178	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GLP1R—type 2 diabetes mellitus	4.33e-05	0.00177	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.22e-05	0.00173	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.17e-05	0.00171	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.16e-05	0.0017	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC2A2—type 2 diabetes mellitus	4.05e-05	0.00166	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IGF1—type 2 diabetes mellitus	4.03e-05	0.00165	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—AKT2—type 2 diabetes mellitus	4.02e-05	0.00165	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CPT1A—type 2 diabetes mellitus	3.96e-05	0.00162	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTR—type 2 diabetes mellitus	3.96e-05	0.00162	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NAMPT—type 2 diabetes mellitus	3.89e-05	0.00159	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—LIPC—type 2 diabetes mellitus	3.86e-05	0.00158	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GCK—type 2 diabetes mellitus	3.86e-05	0.00158	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HBA1—type 2 diabetes mellitus	3.86e-05	0.00158	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.84e-05	0.00157	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SERPINE1—type 2 diabetes mellitus	3.82e-05	0.00157	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ALB—type 2 diabetes mellitus	3.82e-05	0.00156	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.77e-05	0.00154	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CETP—type 2 diabetes mellitus	3.73e-05	0.00153	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3R1—type 2 diabetes mellitus	3.65e-05	0.00149	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—NOS3—type 2 diabetes mellitus	3.65e-05	0.00149	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.59e-05	0.00147	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.57e-05	0.00146	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.54e-05	0.00145	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SNAP25—type 2 diabetes mellitus	3.47e-05	0.00142	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SREBF1—type 2 diabetes mellitus	3.47e-05	0.00142	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PSMD6—type 2 diabetes mellitus	3.47e-05	0.00142	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.42e-05	0.0014	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CTGF—type 2 diabetes mellitus	3.4e-05	0.00139	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HMGCR—type 2 diabetes mellitus	3.37e-05	0.00138	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.3e-05	0.00135	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.3e-05	0.00135	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.2e-05	0.00131	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.17e-05	0.0013	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.13e-05	0.00128	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.13e-05	0.00128	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.06e-05	0.00125	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC2A4—type 2 diabetes mellitus	3e-05	0.00123	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GCG—type 2 diabetes mellitus	3e-05	0.00123	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.89e-05	0.00118	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.71e-05	0.00111	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SRC—type 2 diabetes mellitus	2.7e-05	0.00111	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFA—type 2 diabetes mellitus	2.63e-05	0.00108	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GNB3—type 2 diabetes mellitus	2.59e-05	0.00106	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.59e-05	0.00106	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.58e-05	0.00105	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CAT—type 2 diabetes mellitus	2.54e-05	0.00104	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—APOB—type 2 diabetes mellitus	2.47e-05	0.00101	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TGFB1—type 2 diabetes mellitus	2.41e-05	0.000988	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.4e-05	0.000983	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—LPL—type 2 diabetes mellitus	2.36e-05	0.000965	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.31e-05	0.000945	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GPX1—type 2 diabetes mellitus	2.3e-05	0.000941	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CD36—type 2 diabetes mellitus	2.24e-05	0.000917	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.21e-05	0.000905	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.14e-05	0.000878	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.12e-05	0.000869	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPARA—type 2 diabetes mellitus	2.08e-05	0.000852	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AGT—type 2 diabetes mellitus	2.02e-05	0.000825	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CALM1—type 2 diabetes mellitus	1.98e-05	0.000812	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—APOE—type 2 diabetes mellitus	1.98e-05	0.000809	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—APOA1—type 2 diabetes mellitus	1.95e-05	0.000799	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPARG—type 2 diabetes mellitus	1.72e-05	0.000704	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—INS—type 2 diabetes mellitus	1.69e-05	0.000691	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—AKT1—type 2 diabetes mellitus	1.68e-05	0.000687	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALB—type 2 diabetes mellitus	1.55e-05	0.000633	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-05	0.000606	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-05	0.000606	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.35e-05	0.000554	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AKT1—type 2 diabetes mellitus	6.81e-06	0.000279	CbGpPWpGaD
